Schedule a Meeting
Download Brochure
Table of Content
April 2025
Principal Consultant
Reviewed By
The global rapid medical diagnostic kits market size is calculated at US$ 25.78 in 2024, grew to US$ 28.12 billion in 2025, and is projected to reach around US$ 61.42 billion by 2034. The market is expanding at a CAGR of 9.07% between 2025 and 2034. For detecting and managing infections and diseases, a rapid medical diagnostic test is necessary. As they provide quick results, early treatment is possible, decreasing further complications associated with the infections or diseases.
Rapid medical diagnostic kits are referred to as tools used in the identification and diagnosis of health conditions, for example, infectious diseases. Due to the ease of use, speed, and accuracy, the use of rapid medical diagnostics has become common in hospitals and homes. Affordability, improved convenience, and technological advancements are some other reasons for their increasing demand. The most common rapid diagnostic kit based on lateral flow assays (LFAs) is a pregnancy kit. LFAs can now also be used to detect various infectious diseases. Thus, with the help of rapid medical diagnostic kits, the treatment can be started early, leading to decreased rates of transmission of infection if the results obtained are positive.
For the detection and management of diseases, the use of rapid medical diagnostic kits is important, but in certain cases, the results may not be accurate. Thus, to overcome this challenge, the use or integration of AI algorithms such as convolutional neural network (CNN) applications in the smartphone can be used. With the help of this app, the pictures of the test kits are taken and processed by YOLOv8. It also enables visually impaired individuals to capture the test pictures individually. These images are then analyzed by a CNN classifier. The CNN classifier identifies the results as positive, negative, or invalid. Thus, with the help of AI integration, the sensitivity and specificity of test results are enhanced.
Need For Quick Result
The increasing number of diseases has increased the need for rapid diagnostic kits to have quick results. With the help of quick results, the early detection of infections or diseases is possible. This, in turn, provides various treatment opportunities and helps in the management of the diseases. Early detection can minimize the risk of complications associated with the diseases. At the same time, increased awareness has caused increased demand for rapid medical diagnostic kits. As these kits provide rapid results and ease of use, their use in homecare is increasing for the timely management of diseases.
Lack of Accuracy
The use of rapid medical diagnostic kits has been increasing everywhere as they provide quick results. However, the results obtained may not always be accurate. In some cases, it may provide false positive results, due to which the patient has to undergo the treatment without being affected, or if the patient is affected with the infection, they may not be categorized as an infected patient.
Increased Use of Lateral Flow Tests
Lateral flow tests (LFT), also known as lateral flow immunochromatographic tests, are used to identify targeted substances from the liquid sample. These kits provide results within 15-30 minutes with a small amount of sample, which makes it convenient to use. They can be used for the detection of a variety of samples, including COVID-19, flu, vitamin D, diabetes, cholesterol, and many other infections. Thus, their use has increased in hospitals as well as in home care. To improve sensitivity, selectivity, and accuracy, various technological advances are also being made in the LFTs.
For instance,
The graph displays the sensitivity data of lateral flow tests (LFTs) for various infections. This indicates that the IBV and EV diagnostic kits exhibit lower sensitivity, which needs to be increased to prevent misdiagnosis of the infections. At the same time, HCV, HBV, and IAV yield precise results, while HIV, HAV, and SARS-CoV-2 demonstrate accurate sensitivity, providing accurate detection of the infections and thereby increasing their market adoption. Thus, researchers must focus on developing more effective IBV and EV diagnostic kits, which will ultimately promote the growth of the rapid medical diagnostic kits market.
By product type, the over-the-counter (OTC) kits segment dominated the rapid medical diagnostic kits market in 2024 and is estimated to be the fastest-growing during the forecast period. The use of an OTC kit is the preferred choice within the population as it provides convenience and is affordable. Due to the rapid results, it also saves a lot of time. With the help of OTC kits, the early detection of infections is possible, leading to early treatment.
By technology type, the lateral flow technology segment dominated the market in 2024 and is expected to be the fastest-growing during the predicted period. The lateral flow technology provides quick results as well as being easy to handle and carry; thus, it is suitable for use in point-of-care testing. It provides improved sensitivity and minimizes the errors associated with false negative results. This causes a continuous rise in their demand.
By application type, the blood glucose testing segment dominated the global rapid medical diagnostic kits market in 2024 and is estimated to be the fastest-growing during the forecast period. Blood glucose testing kits are easy to use and, thus, were used for self-monitoring the glucose levels in the home. It provided accurate results. Furthermore, it helped in the proper management of diabetes.
By application type, the infectious disease testing segment is anticipated to grow significantly during the forecast period. The increased awareness in the population is increasing the demand for the use of infectious disease testing. Thus, to meet the public demand for cost-effective, rapid diagnosis kits are being used in hospitals and clinics.
By end-user type, the hospital segment dominated the rapid medical diagnostic kits market in 2024. The hospitals have specialized staff to carry out the testing efficiently. They provided a variety of testing kits depending on the patient’s infection. Due to the rapid results obtained by the kit, the treatment option was made available without any delay.
By end-user type, the home care segment is predicted to be significantly growing during the forecast period. The rapid medical diagnostic kits provide ease of access and, thus, are convenient to use at home. Increased health awareness caused the population to monitor their health regularly, which promotes the use of diagnostic kits at home.
North America dominated the rapid medical diagnostic kits market share by 37% in 2024. The well-established healthcare systems are responsible for this dominance. Healthcare systems are investing in the development of innovative diagnostic kits similar to COVID-19 rapid diagnostic tests. Thus, after gaining approval from the regulatory bodies, these kits enhanced the growth of the market.
The U.S. consists of advanced healthcare facilities that focus on innovations and technologies. This has increased the development of rapid diagnostic kits and tests. The regulatory bodies also play an important role in the approval of these kits. This helps in providing ease of distribution and results in market growth.
There are various collaborations between pharmaceutical companies where they focus on the development of new and innovative rapid diagnostic kits. The government also invests in the research and development sectors for these developments, due to which the manufacturing process is carried out easily. All these factors contribute to the growth of the market.
Asia Pacific is estimated to host the fastest-growing rapid medical diagnostic kits market during the forecast period. Asia Pacific has to face an increasing rate of infections and diseases due to the increased population. Thus, to identify the infection and to control it, the need for rapid diagnostic kits in the market increases, encouraging market growth.
Due to the large population rates, the demand for diagnostic kits increases. Thus, to meet the patient's needs, the healthcare systems and the government focus on rapid development or manufacturing of the kits. At the same time, due to technological advances, they also take part in the development of new rapid medical diagnostic kits.
The rapid medical diagnostic kits developed in India are affordable and thus are used by a wide range of the population. At the same time, to make these kits available in rural areas, various government bodies are participating by raising awareness. The industries in India also contribute to the increased rate of production, which drives the market.
Europe is expected to show lucrative growth in the rapid medical diagnostic kits market during the forecast period. Due to the increased awareness after the pandemic of Covid-19 Europe is continuously investing in the development of diagnostic kits for other infections or diseases. Similarly, the use of home-care rapid diagnostic kits is increasing due to the increased demand of the population.
Germany consists of well-developed healthcare facilities and industries along with government support. Due to all these factors, the manufacturing and development of new and innovative rapid diagnostic kits is encouraged. These kits are used highly in hospitals as well as in home care, boosting the market growth.
The government of the UK is actively supporting pharmaceutical companies in the development and healthcare systems for the proper distribution and use of rapid diagnostic kits. The increased awareness played an important role in driving the development process. This caused the increased demand for early detection of infection with the use of rapid diagnostic kits.
In March 2025, Javier Gonzalez, a senior researcher and a professor of health at the University of Bath in the U.K., stated that continuous glucose monitors (CGMs) are tools that may not provide perfectly accurate results but are always a better choice than not having the measurements at all.
In June 2024, the U.S. Ambassador said to Kenya Meg Whitman that significant challenges in accessing affordable and high-quality healthcare commodities were faced by Kenya and many other African countries, but Kenyans have never backed down. Revital saw an opportunity where others saw difficulties to make a difference, harnessing the power of innovation, thus, expanding the quality of healthcare in Kenya and Africa.
By Product
By Technology
By Application
By End-user
By Region
April 2025
April 2025
April 2025
April 2025